# Summary Table of Adult ADHD Diagnostic Tools: Clinical Rating Scales and Diagnostic Interviews

| Study                       | Sample Size ADHD                                                  | Age (Mean ± SD) ADHD              | Gender ADHD           | Sample Size Controls (type)                                                | Age (Mean ± SD) Controls | Gender Controls        | Measure Name                                      | Diagnostic Accuracy | Sensitivity               | Specificity                                                  | NPV                          | PPV                          | Notes                                                                                                |
| --------------------------- | ----------------------------------------------------------------- | --------------------------------- | --------------------- | -------------------------------------------------------------------------- | ------------------------ | ---------------------- | ------------------------------------------------- | ------------------- | ------------------------- | ------------------------------------------------------------ | ---------------------------- | ---------------------------- | ---------------------------------------------------------------------------------------------------- |
| Vizgaitis et al. (2023)     | 27                                                                | Not reported                      | 11 males, 16 females  | 95 (clinical controls seeking ADHD assessment but not diagnosed with ADHD) | Not reported             | 44 males, 51 females   | CAARS-S:L (ADHD Index)                            | Weak accuracy       | 0.556                     | 0.621                                                        | 0.831                        | 0.294                        | False positives most frequently diagnosed with anxiety disorders (33.3%) or depressive disorders (33.3%). All CAARS-S:L scales demonstrated very low PPV. |
| Vizgaitis et al. (2023)     | 27                                                                | Not reported                      | 11 males, 16 females  | 95 (clinical controls)                                                     | Not reported             | 44 males, 51 females   | CAARS-S:L (DSM-IV Inattentive Symptoms)           | Low                 | 1.000                     | 0.200                                                        | 1.000                        | 0.262                        | Highest sensitivity and NPV among all CAARS-S:L scales                                               |
| Vizgaitis et al. (2023)     | 27                                                                | Not reported                      | 11 males, 16 females  | 95 (clinical controls)                                                     | Not reported             | 44 males, 51 females   | CAARS-S:L (DSM-IV Hyperactive/Impulsive Symptoms) | Low                 | 0.630                     | 0.653                                                        | 0.861                        | 0.340                        | Better specificity than inattentive symptoms scale                                                   |
| Vizgaitis et al. (2023)     | 27                                                                | Not reported                      | 11 males, 16 females  | 95 (clinical controls)                                                     | Not reported             | 44 males, 51 females   | CAARS-S:L (DSM-IV ADHD Total Symptoms)            | Low                 | 0.889                     | 0.305                                                        | 0.906                        | 0.267                        | High sensitivity but low specificity                                                                 |
| Harrison et al. (2016)      | 201                                                               | 21.2 ± 4.8                        | 150 males, 99 females | 404 (clinical controls with attention/learning problems)                   | 22.2 ± 6.3               | 189 males, 318 females | CAARS-S (Self-Report)                             | Weak                | Not reported              | Not reported                                                 | Not reported                 | Not reported                 | High false positive and false negative rate, suggesting CAARS should not be the main method for diagnosing ADHD |
| Van Voorhees et al. (2011)  | 183 (ADHD diagnoses: 26.3% Combined, 33.1% Inattentive, 8.9% NOS) | 32 (mean), 28 (median), 20 (mode) | 38.5% females         | 86 (clinical controls with various diagnoses)                              | Same as ADHD             | Similar as ADHD        | CAARS-S and CAARS-O (Observer)                    | Not reported        | Not reported              | Not reported                                                 | Not reported                 | Not reported                 | Rating scales do not effectively distinguish between ADHD and other adult psychiatric disorders; sample included 349 adults ages 18-70 |
| van de Glind et al. (2013)  | Not fully reported                                                | Not reported                      | Not reported          | Not fully reported (substance use disorder patients)                       | Not reported             | Not reported           | ASRS                                              | Good                | 0.84                      | 0.66                                                         | 0.97                         | 0.26                         | The ASRS is sensitive in detecting ADHD, but not in detecting other externalizing disorders          |
| Bakare & Jordanova (2020)   | Not explicitly reported                                           | 45 ± 6.95 (total sample)          | Not reported by group | 69 total participants (adults referred to ADHD clinic)                     | Age range: 30-63         | Not reported           | WURS-brief                                        | Respectable         | 0.897 (vs DIVA or CAADID) | 0.133 (vs DIVA or CAADID)                                    | 0.333                        | 0.729                        | Sample consisted of 69 adults referred to a specialist adult ADHD outpatients clinic                 |
| Grogan et al. (2017)        | Not reported                                                      | Not reported                      | Not reported          | Not reported                                                               | Not reported             | Not reported           | CAARS (Inattention/Memory Problems)               | Moderate            | 0.82                      | 0.81 (vs non-clinical controls); 0.50 (vs clinical controls) | Not reported                 | Not reported                 | Specificity drops substantially when comparing with clinical controls vs. non-clinical controls      |
| Grogan et al. (2017)        | Not reported                                                      | Not reported                      | Not reported          | Not reported                                                               | Not reported             | Not reported           | CAARS (DSM Inattentive Symptoms)                  | Moderate            | 0.95                      | 0.74 (vs non-clinical controls); 0.43 (vs clinical controls) | Not reported                 | Not reported                 | Specificity drops substantially when comparing with clinical controls vs. non-clinical controls      |
| Grogan et al. (2017)        | Not reported                                                      | Not reported                      | Not reported          | Not reported                                                               | Not reported             | Not reported           | CAARS (DSM Total Symptoms)                        | Moderate            | 0.76                      | 0.78 (vs non-clinical controls); 0.36 (vs clinical controls) | Not reported                 | Not reported                 | Specificity drops substantially when comparing with clinical controls vs. non-clinical controls      |
| Mehringer et al. (2002)     | Not fully reported                                                | Not reported                      | Not reported          | Not reported                                                               | Not reported             | Not reported           | Assessment of Hyperactivity and Attention (AHA)   | Good                | 0.80                      | 0.60                                                         | 0.99 (in general population) | 0.04 (in general population) | AUC = 0.79; Total predictive value = 0.70; Useful as screening tool but requires further evaluation for diagnosis |
| Palma-Álvarez et al. (2023) | Not reported                                                      | Not reported                      | Not reported          | Not reported (adults with substance use disorders)                         | Not reported             | Not reported           | MINI-Plus ADHD module                             | Good                | 0.75                      | 0.91                                                         | 0.96                         | 0.60                         | Kappa = 0.60; Validated in adults with substance use disorders                                       |

*Note: CAARS = Conners' Adult ADHD Rating Scale; ASRS = Adult ADHD Self-Report
Scale; WURS = Wender Utah Rating Scale; MINI = Mini International
Neuropsychiatric Interview; NPV = Negative Predictive Value; PPV = Positive
Predictive Value; DIVA = Diagnostic Interview for ADHD in Adults; CAADID =
Conners' Adult ADHD Diagnostic Interview for DSM-IV*
